Does the Effect of Beta-Blockers on Outcomes in Patients with Advanced Chronic Systolic Heart Failure Vary by Baseline Systolic Blood Pressure? Insights from the BEST Trial

被引：0
作者：
White, Michel [1 ]
Desai, Ravi V.
Mujib, Marjan
Ahmed, Mustafa I.
Aban, Immaculada
Fonarow, Gregg [2 ]
Deedwania, Prakash [3 ]
Aronow, Wilbert S. [4 ]
Waagstein, Finn [5 ]
Ahmed, Ali [6 ]
机构：
[1] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada
[2] Univ Calif Los Angeles, Los Angeles, CA USA
[3] Univ Calif San Francisco, Fresno, CA USA
[4] New York Med Coll, Valhalla, NY 10595 USA
[5] Sahlgrens Univ Hosp, Gothenburg, Sweden
[6] Univ Alabama, Alabama Vet Affairs Med Ctr, Birmingham, AL USA
来源：
JOURNAL OF CARDIAC FAILURE | 2010年 / 16卷 / 08期
关键词：
D O I：
10.1016/j.cardfail.2010.06.222
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
205
引用
收藏
页码：S64 / S65
页数：2
相关论文
共 50 条
[21]   Use of beta-blockers in elderly patients with acute heart failure and depressed left ventricular systolic function [J].
Joo, S-J. ;
Choi, J-H. ;
Kim, S-Y. ;
Kim, K-S. ;
Ryu, K-H. .
EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 :S319-S319
[22]   Narrow QRS duration predicts improvement of left ventricular systolic function by beta-blockers in chronic heart failure [J].
Taniguchi, R. ;
Furukawa, Y. ;
Sato, Y. ;
Nishi, K. ;
Takatsu, Y. ;
Fujiwara, H. ;
Morimoto, T. ;
Kita, T. ;
Kimura, T. .
EUROPEAN HEART JOURNAL, 2010, 31 :853-853
[23]   PLASMA NOR-EPINEPHRINE LEVELS AND MORTALITY IN PATIENTS WITH ADVANCED CHRONIC SYSTOLIC HEART FAILURE: INSIGHTS FROM THE BEST STUDY [J].
Ahmed, Mustafa I. ;
Mujib, Marjan ;
Aronow, Wilbert S. ;
Filippatos, Gerasimos ;
Deedwania, Prakash ;
Ahmed, Ali .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
[24]   Effect of Baseline and Changes in Systolic Blood Pressure Over Time on the Effectiveness of Valsartan in the Valsartan Heart Failure Trial [J].
Anand, Inder S. ;
Rector, Thomas S. ;
Kuskowski, Michael ;
Thomas, Sabu ;
Holwerda, N. J. ;
Cohn, Jay N. .
CIRCULATION-HEART FAILURE, 2008, 1 (01) :34-42
[25]   Rofecoxib but not celecoxib increases systolic blood pressure in hypertensive patients treated with ACE inhibitors and beta-blockers [J].
White, WB ;
Whelton, A ;
Fort, JG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) :249A-249A
[26]   Effect of comorbidities on outcomes and ivabradine effects in patients with chronic systolic heart failure in the SHIFT trial [J].
Bohm, Servier M. ;
Borer, J. S. ;
Ford, I. ;
Lainscak, M. ;
Komajda, M. ;
Robertson, M. ;
Tavazzi, L. ;
Swedberg, K. .
EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 :266-266
[27]   Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF) [J].
Serenelli, Matteo ;
Boehm, Michael ;
Inzucchi, Silvio E. ;
Kober, Lars ;
Kosiborod, Mikhail N. ;
Martinez, Felipe A. ;
Ponikowski, Piotr ;
Sabatine, Marc S. ;
Solomon, Scott D. ;
DeMets, David L. ;
Bengtsson, Olof ;
Sjostrand, Mikaela ;
Langkilde, Anna Maria ;
Anand, Inder S. ;
Chiang, Chern-En ;
Chopra, Vijay K. ;
de Boer, Rudolf A. ;
Diez, Mirta ;
Dukat, Andrej ;
Ge, Junbo ;
Howlett, Jonathan G. ;
Katova, Tzvetana ;
Kitakaze, Masafumi ;
Ljungman, Charlotta E. A. ;
Verma, Subodh ;
Docherty, Kieran F. ;
Jhund, Pardeep S. ;
McMurray, John J., V .
EUROPEAN HEART JOURNAL, 2020, 41 (36) :3402-3418
[28]   Rofecoxib, but not celecoxib, increases systolic blood pressure in hypertensive patients treated with ACE inhibitors and beta-blockers [J].
White, WB ;
Whelton, A ;
Fort, JG .
JOURNAL OF HYPERTENSION, 2002, 20 :S82-S82
[29]   Systolic blood pressure, heart rate, and outcomes in patients with coronary disease and heart failure [J].
Elgendy, Islam Y. ;
Hill, James A. ;
Szady, Anita D. ;
Gong, Yan ;
Cooper-DeHoff, Rhonda M. ;
Pepine, Carl J. .
ESC HEART FAILURE, 2020, 7 (01) :124-130
[30]   Systolic blood pressure and outcomes in patients hospitalized with acute heart failure - Reply [J].
Gheorghiade, Mihai ;
Fonarow, Gregg C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (08) :808-809
12345